FDA Inspection 794037 — Przedsiebiorstwo Farmaceutyczne Jelfa SA

Przedsiebiorstwo Farmaceutyczne Jelfa SA — FEI 3004680543

The FDA completed an inspection of Przedsiebiorstwo Farmaceutyczne Jelfa SA on May 15, 2012 in Jelenia Gora. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 10 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 15, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jelenia Gora (Poland)

Citations

IDCFRDescription
108621 CFR 211.22(b)Adequate lab facilities not available
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
145121 CFR 211.113(b)Procedures for sterile drug products
191221 CFR 211.166(a)Written program not followed
203221 CFR 211.194(b)Test method modification records not maintained
239921 CFR 211.194(a)(2)Laboratory Test Method Verification
240121 CFR 211.194(a)(4)Complete Test Data
430321 CFR 211.67(b)Written procedures fail to include
441021 CFR 211.194(a)(5)Calculations performed are in the records